Biochemical Pathway Analysis of Gastric Atrophy
Aim: Pathway analysis of gastric atrophy to find new molecular prospective of disease.
Background: Gastric atrophy as a process which is accompanied with “loss of glans” in stomach can be considered as a risk factor of
gastric cancer. Here, the correlated biochemical pathways to the disorder have been analyzed via protein-protein interaction (PPI)
Methods: The genes related to gastric atrophy were retrieved by STRING database and organized in a network by Cytoscape. Three
significant clusters were determined by ClusterONE plug-in of Cytoscape. The elements of cluster-2 which contained all central nodes
of the network were enriched by ClueGO and the biochemical pathways discussed in details.
Results: The number of seven central nodes (which are included in cluster-2); INS, TP53, IL6, TNF, SRC, MYC, and IL8 were
identified. The biochemical pathways related to the elements of cluster-2 were determined and clustered in nine groups. The pathways
were discussed in details.
Conclusion: Pathway analysis indicates that the introduced central genes of the network can be considered as biomarkers of gastric
Keywords: Gastric atrophy, Network analysis, Gene, Biochemical pathway, Central node.
(Please cite as: Rezaei Tavirani M, Rezaei Tavirani S, Tajik Rostami F. Biochemical pathway analysis of gastric
atrophy. Gastroenterol Hepatol Bed Bench 2018;11(2):118-124).
Genta R. Gastric atrophy and atrophic gastritis—nebulous concepts in search of a definition. Alimentary pharmacology & therapeutics. 1998;12(s1):17-23.
Dixon M. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut. 2001;49(1):2-4.
Nomura S, Ida K, Terao S, Adachi K, Kato T, Watanabe H, et al. Endoscopic diagnosis of gastric mucosal atrophy: multicenter prospective study. Digestive Endoscopy. 2014;26(6):709-19.
Togawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, et al. Interleukin‐2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter. 2005;10(3):172-8.
Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, Lopes C, et al. -765G> C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World journal of gastroenterology: WJG. 2006;12(34):5473.
Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. Journal of the National Cancer Institute. 2004;96(5):388-96.
Beales I, Crabtree JE, Scunes D, Covacci A, Calam J. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. European journal of gastroenterology & hepatology. 1996;8(7):645-9.
Zamanian-Azodi M, Rezaei-Tavirani M, Rahmati-Rad S, Hasanzadeh H, Tavirani MR, Seyyedi SS. Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer. Gastroenterology and Hepatology from bed to bench. 2015;8(3):215.
Zali H, REZAEI TM. Meningioma protein-protein interaction network. 2014.
Safaei A, Tavirani MR, Oskouei AA, Azodi MZ, Mohebbi SR, Nikzamir AR. Protein-protein interaction network analysis of cirrhosis liver disease. Gastroenterology and Hepatology from bed to bench. 2016;9(2):114.
Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Molecular cell. 2004;15(6):853-65.
Safari‐Alighiarloo N, Taghizadeh M, Tabatabaei SM, Shahsavari S, Namaki S, Khodakarim S, et al. Identification of new key genes for type 1 diabetes through construction and analysis of protein–protein interaction networks based on blood and pancreatic islet transcriptomes. Journal of diabetes. 2017;9(8):764-77.
Barabási A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nature reviews genetics. 2011;12(1):56.
Rezaei-Tavirani M, Zamanian-Azodi M, Rajabi S, Masoudi-Nejad A, Rostami-Nejad M, Rahmatirad S. Protein Clustering and Interactome Analysis in Parkinson and Alzheimer's Diseases. Archives of Iranian Medicine (AIM). 2016;19(2).
Abbaszadeh H-A, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er: YAG laser and cyclosporin A effect on cell cycle regulation of human gingival fibroblast cells. Journal of lasers in medical sciences. 2017;8(3):143.
Rezaei-Tavirani M, Rezaei-Tavirani M, Mansouri V, Mahdavi SM, Valizadeh R, Rostami-Nejad M, et al. Introducing crucial protein panel of gastric adenocarcinoma disease. Gastroenterology and Hepatology from bed to bench. 2017;10(1):21.
Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ. 2016;4:e2775.
Chen L, Zhang Y-H, Zheng M, Huang T, Cai Y-D. Identification of compound–protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds. Molecular Genetics and Genomics. 2016;291(6):2065-79.
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic acids research. 2016:gkw937.
Zhi J, Sun J, Wang Z, Ding W. Support vector machine classifier for prediction of the metastasis of colorectal cancer. International journal of molecular medicine. 2018.
Cheng L, Liu P, Leung K-S. SMILE: a novel procedure for subcellular module identification with localisation expansion. IET Systems Biology. 2017.
Maddi A, Eslahchi C. Discovering overlapped protein complexes from weighted PPI networks by removing inter-module hubs. Scientific Reports. 2017;7(1):3247.
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091-3.
Mlecnik B, Galon J, Bindea G. Comprehensive functional analysis of large lists of genes and proteins. Journal of proteomics. 2018;171:2-10.
Rezaei–Tavirani M, Ahmadi N, Naderi N, Abdi S. Pancreatic adenocarcinoma protein-protein interaction network analysis. Gastroenterology and Hepatology from bed to bench. 2017:85-92.
Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. The Journal of clinical investigation. 2001;107(1):7-11.
Zeng J, Wang L, Li Q, Li W, Björkholm M, Jia J, et al. FoxM1 is up‐regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1. The Journal of pathology. 2009;218(4):419-27.
Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, et al. Toll‐Like Receptor 4+ 3725 G/C Polymorphism, Helicobacter pylori Seropositivity, and the Risk of Gastric Atrophy and Gastric Cancer in Japanese. Helicobacter. 2009;14(1):47-53.
Kennedy CL, Najdovska M, Jones GW, McLeod L, Hughes NR, Allison C, et al. The molecular pathogenesis of STAT3‐driven gastric tumourigenesis in mice is independent of IL‐17. The Journal of pathology. 2011;225(2):255-64.
Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proceedings of the National Academy of Sciences. 2008;105(3):1003-8.
Litwinoff E, Hurtado Del Pozo C, Ramasamy R, Schmidt A. Emerging targets for therapeutic development in diabetes and its complications: the RAGE signaling pathway. Clinical Pharmacology & Therapeutics. 2015;98(2):135-44.
Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: A meta‐analysis and systematic review of the literature. Inflammatory bowel diseases. 2010;16(6):1077-84.
Tummuru MK, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL‐8 in gastric epithelial cells. Molecular microbiology. 1995;18(5):867-76.
Weinberg W, Wilairatana P, Meddings JB, Ho M, Vannaphan S, Looareesuwan S. Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria. Clinical infectious diseases. 1997;24(3):430-5.
Rahbari M, Pecqueux M, Reissfelder C, Welsch T, Weitz J, Rahbari N, et al. Exosomal Glypican-3 is a diagnostic and prognostic biomarker in gastric cancer. Zeitschrift für Gastroenterologie. 2017;55(08):KV 015.
Wang S, Wu Z, Zhou M, Liao W. Effect of GPC1 on epithelial-to-mesenchymal transition and stemness and interaction with ITGB1 in gastric cancer. American Society of Clinical Oncology; 2017.